About The Study: This economic evaluation estimates that expanded Medicare coverage for glucagon-like peptide-1 receptor agonists (GLP-1RAs) would increase access and reduce obesity-related comorbidities but impose substantial costs over 10 years. Even with a moderate scenario (5% uptake, 20% adherence, and 30% additional price discount), net spending was still projected to reach $8 billion over a decade, underscoring the need for further price reductions, lower-cost strategies to prevent weight regain, and reductions in spending on low-value care.

Millions worldwide who turn to wearable devices for sleep insights are set to benefit from recommendations on the use of wearable consumer health trackers (CHTs) for sleep measurement released by the World Sleep Society.

Most people living in cities in Low- and Middle-Income Countries can reach primary care clinics within 30 minutes – yet average quality of care remains poor with clinicians failing to make correct diagnoses or implement appropriate treatments, new studies reveal.

A new study published in the Bulletin of the World Health Organisation (WHO) calls for urgent action to limit plastic waste in these essential diagnostic tools.

Researchers from Heriot-Watt University and the University of Edinburgh propose limiting how much plastic is used in test kits to curb unnecessary plastic waste. 

Innovative statistical method helps determine ideal threshold times in restricted mean survival time analyses